APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biopharmaceutical CRO

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biopharmaceutical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026194 pages

Choose your research edition.

Industry ResearchBiopharmaceutical CRO Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Biopharmaceutical CRO Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Biopharmaceutical CRO Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biopharmaceutical CRO Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biopharmaceutical CRO Market Analysis and Forecast 2026-2032223 pages · $4,950 USD

Market perspective

The global Biopharmaceutical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biopharmaceutical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biopharmaceutical CRO include WuXi AppTec, WuXi Biologics, Hangzhou Tigermed, Pharmaron Beijing, ICON, PPD, BioPharma Services, TriStar Technology Group and Fortrea, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biopharmaceutical CRO market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biopharmaceutical CRO and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biopharmaceutical CRO revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biopharmaceutical CRO market size, projected growth trends, production technologies, key applications, and end-use industries.

Biopharmaceutical CRO Segment by Company

WuXi AppTec

WuXi Biologics

Hangzhou Tigermed

Pharmaron Beijing

ICON

PPD

BioPharma Services

TriStar Technology Group

Fortrea

Eurofins BioPharma Services

Medicilon

Asymchem

UBC

SanaClis

TFS HealthScience

Parexel

Biopharmaceutical CRO Segment by Type

Full-service CRO

Specialized CRO

Biopharmaceutical CRO Segment by Application

SMBs

Large Enterprises

Biopharmaceutical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biopharmaceutical CRO in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceutical CRO industry.

Chapter 3: Detailed analysis of Biopharmaceutical CRO companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical CROrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biopharmaceutical CRO Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Full-service CRO Table 3. Key Players of Specialized CRO Table 4. Global Biopharmaceutical CRO Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of SMBs Table 6. Key Players of Large Enterprises Table 7. Global Biopharmaceutical CRO Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Biopharmaceutical CRO Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Biopharmaceutical CRO Market Share by Region (2021-2026) Table 10. Global Biopharmaceutical CRO Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Biopharmaceutical CRO Market Share by Region (2027-2032) Table 12. Biopharmaceutical CRO Industry Trends Table 13. Biopharmaceutical CRO Industry Drivers Table 14. Biopharmaceutical CRO Industry Opportunities and Challenges Table 15. Biopharmaceutical CRO Industry Restraints Table 16. Global Biopharmaceutical CRO Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Biopharmaceutical CRO Revenue Market Share by Company (2021-2026) Table 18. Global Biopharmaceutical CRO Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Biopharmaceutical CRO Key Company Head Office and Area Served Table 20. Global Biopharmaceutical CRO Company, Product Type & Application Table 21. Global Biopharmaceutical CRO Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Biopharmaceutical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Biopharmaceutical CRO Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biopharmaceutical CRO Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Biopharmaceutical CRO Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Biopharmaceutical CRO Revenue Market Share by Type (2021-2026) Table 28. Global Biopharmaceutical CRO Revenue Market Share by Type (2027-2032) Table 29. Global Biopharmaceutical CRO Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biopharmaceutical CRO Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Biopharmaceutical CRO Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Biopharmaceutical CRO Revenue Market Share by Application (2021-2026) Table 33. Global Biopharmaceutical CRO Revenue Market Share by Application (2027-2032) Table 34. WuXi AppTec Company Information Table 35. WuXi AppTec Business Overview Table 36. WuXi AppTec Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. WuXi AppTec Biopharmaceutical CRO Product Portfolio Table 38. WuXi AppTec Recent Development Table 39. WuXi Biologics Company Information Table 40. WuXi Biologics Business Overview Table 41. WuXi Biologics Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. WuXi Biologics Biopharmaceutical CRO Product Portfolio Table 43. WuXi Biologics Recent Development Table 44. Hangzhou Tigermed Company Information Table 45. Hangzhou Tigermed Business Overview Table 46. Hangzhou Tigermed Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio Table 48. Hangzhou Tigermed Recent Development Table 49. Pharmaron Beijing Company Information Table 50. Pharmaron Beijing Business Overview Table 51. Pharmaron Beijing Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Pharmaron Beijing Biopharmaceutical CRO Product Portfolio Table 53. Pharmaron Beijing Recent Development Table 54. ICON Company Information Table 55. ICON Business Overview Table 56. ICON Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. ICON Biopharmaceutical CRO Product Portfolio Table 58. ICON Recent Development Table 59. PPD Company Information Table 60. PPD Business Overview Table 61. PPD Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. PPD Biopharmaceutical CRO Product Portfolio Table 63. PPD Recent Development Table 64. BioPharma Services Company Information Table 65. BioPharma Services Business Overview Table 66. BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. BioPharma Services Biopharmaceutical CRO Product Portfolio Table 68. BioPharma Services Recent Development Table 69. TriStar Technology Group Company Information Table 70. TriStar Technology Group Business Overview Table 71. TriStar Technology Group Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. TriStar Technology Group Biopharmaceutical CRO Product Portfolio Table 73. TriStar Technology Group Recent Development Table 74. Fortrea Company Information Table 75. Fortrea Business Overview Table 76. Fortrea Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Fortrea Biopharmaceutical CRO Product Portfolio Table 78. Fortrea Recent Development Table 79. Eurofins BioPharma Services Company Information Table 80. Eurofins BioPharma Services Business Overview Table 81. Eurofins BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio Table 83. Eurofins BioPharma Services Recent Development Table 84. Medicilon Company Information Table 85. Medicilon Business Overview Table 86. Medicilon Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Medicilon Biopharmaceutical CRO Product Portfolio Table 88. Medicilon Recent Development Table 89. Asymchem Company Information Table 90. Asymchem Business Overview Table 91. Asymchem Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Asymchem Biopharmaceutical CRO Product Portfolio Table 93. Asymchem Recent Development Table 94. UBC Company Information Table 95. UBC Business Overview Table 96. UBC Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. UBC Biopharmaceutical CRO Product Portfolio Table 98. UBC Recent Development Table 99. SanaClis Company Information Table 100. SanaClis Business Overview Table 101. SanaClis Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. SanaClis Biopharmaceutical CRO Product Portfolio Table 103. SanaClis Recent Development Table 104. TFS HealthScience Company Information Table 105. TFS HealthScience Business Overview Table 106. TFS HealthScience Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. TFS HealthScience Biopharmaceutical CRO Product Portfolio Table 108. TFS HealthScience Recent Development Table 109. Parexel Company Information Table 110. Parexel Business Overview Table 111. Parexel Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Parexel Biopharmaceutical CRO Product Portfolio Table 113. Parexel Recent Development Table 114. North America Biopharmaceutical CRO Market Size by Type (2021-2026) & (US$ Million) Table 115. North America Biopharmaceutical CRO Market Size by Type (2027-2032) & (US$ Million) Table 116. North America Biopharmaceutical CRO Market Size by Application (2021-2026) & (US$ Million) Table 117. North America Biopharmaceutical CRO Market Size by Application (2027-2032) & (US$ Million) Table 118. North America Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Biopharmaceutical CRO Market Size by Country (2021-2026) Table 120. North America Biopharmaceutical CRO Market Size by Country (2027-2032) Table 121. Europe Biopharmaceutical CRO Market Size by Type (2021-2026) & (US$ Million) Table 122. Europe Biopharmaceutical CRO Market Size by Type (2027-2032) & (US$ Million) Table 123. Europe Biopharmaceutical CRO Market Size by Application (2021-2026) & (US$ Million) Table 124. Europe Biopharmaceutical CRO Market Size by Application (2027-2032) & (US$ Million) Table 125. Europe Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Biopharmaceutical CRO Market Size by Country (2021-2026) Table 127. Europe Biopharmaceutical CRO Market Size by Country (2027-2032) Table 128. China Biopharmaceutical CRO Market Size by Type (2021-2026) & (US$ Million) Table 129. China Biopharmaceutical CRO Market Size by Type (2027-2032) & (US$ Million) Table 130. China Biopharmaceutical CRO Market Size by Application (2021-2026) & (US$ Million) Table 131. China Biopharmaceutical CRO Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Biopharmaceutical CRO Market Size by Type (2021-2026) & (US$ Million) Table 133. Asia Biopharmaceutical CRO Market Size by Type (2027-2032) & (US$ Million) Table 134. Asia Biopharmaceutical CRO Market Size by Application (2021-2026) & (US$ Million) Table 135. Asia Biopharmaceutical CRO Market Size by Application (2027-2032) & (US$ Million) Table 136. Asia Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Biopharmaceutical CRO Market Size by Country (2021-2026) Table 138. Asia Biopharmaceutical CRO Market Size by Country (2027-2032) Table 139. South America, Middle East & Africa Biopharmaceutical CRO Market Size by Type (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa Biopharmaceutical CRO Market Size by Type (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa Biopharmaceutical CRO Market Size by Application (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Biopharmaceutical CRO Market Size by Application (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. South America, Middle East & Africa Biopharmaceutical CRO Market Size by Country (2021-2026) Table 145. South America, Middle East & Africa Biopharmaceutical CRO Market Size by Country (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Biopharmaceutical CRO Product Image Figure 2. Global Biopharmaceutical CRO Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biopharmaceutical CRO Market Share by Type: 2025 VS 2032 Figure 4. Full-service CRO Image Figure 5. Specialized CRO Image Figure 6. Global Biopharmaceutical CRO Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Biopharmaceutical CRO Market Share by Application: 2025 VS 2032 Figure 8. SMBs Image Figure 9. Large Enterprises Image Figure 10. Global Biopharmaceutical CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 12. Global Biopharmaceutical CRO Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Biopharmaceutical CRO Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Biopharmaceutical CRO Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Biopharmaceutical CRO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biopharmaceutical CRO Revenue Market Share by Type (2021-2032) Figure 19. Global Biopharmaceutical CRO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biopharmaceutical CRO Revenue Market Share by Application (2021-2032) Figure 21. North America Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 22. North America Biopharmaceutical CRO Market Share by Type (2021-2032) Figure 23. North America Biopharmaceutical CRO Market Share by Application (2021-2032) Figure 24. North America Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 25. United States Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 26. Canada Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 28. Europe Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 29. Europe Biopharmaceutical CRO Market Share by Type (2021-2032) Figure 30. Europe Biopharmaceutical CRO Market Share by Application (2021-2032) Figure 31. Europe Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 32. Germany Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 33. France Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 35. Italy Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 36. Russia Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 38. China Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 39. China Biopharmaceutical CRO Market Share by Type (2021-2032) Figure 40. China Biopharmaceutical CRO Market Share by Application (2021-2032) Figure 41. Asia Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 42. Asia Biopharmaceutical CRO Market Share by Type (2021-2032) Figure 43. Asia Biopharmaceutical CRO Market Share by Application (2021-2032) Figure 44. Asia Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 45. Japan Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 49. India Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 50. Australia Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Biopharmaceutical CRO Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Biopharmaceutical CRO Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Biopharmaceutical CRO Market Share by Country (2021-2032) Figure 55. Brazil Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 60. UAE Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 62. Chile Biopharmaceutical CRO Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • Full-service CRO
  • Specialized CRO
Applications
  • SMBs
  • Large Enterprises
Companies covered
  • WuXi AppTec
  • WuXi Biologics
  • Hangzhou Tigermed
  • Pharmaron Beijing
  • ICON
  • PPD
  • BioPharma Services
  • TriStar Technology Group
  • Fortrea
  • Eurofins BioPharma Services
  • Medicilon
  • Asymchem
  • UBC
  • SanaClis
  • TFS HealthScience
  • Parexel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biopharmaceutical CRO Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Full-service CRO
  5. 1.2.3 Specialized CRO
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Biopharmaceutical CRO Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 SMBs
  9. 1.3.3 Large Enterprises
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Biopharmaceutical CRO Growth Trends by Region
  12. 1.5.1 Global Biopharmaceutical CRO Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Biopharmaceutical CRO Market Size by Region (2021-2026)
  14. 1.5.3 Biopharmaceutical CRO Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Biopharmaceutical CRO Market Dynamics
  1. 2.1 Biopharmaceutical CRO Industry Trends
  2. 2.2 Biopharmaceutical CRO Industry Drivers
  3. 2.3 Biopharmaceutical CRO Industry Opportunities and Challenges
  4. 2.4 Biopharmaceutical CRO Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biopharmaceutical CRO Revenue by Company (2021-2026)
  2. 3.2 Global Biopharmaceutical CRO Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biopharmaceutical CRO Key Company Head office and Area Served
  4. 3.4 Global Biopharmaceutical CRO Company, Product Type & Application
  5. 3.5 Global Biopharmaceutical CRO Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biopharmaceutical CRO Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biopharmaceutical CRO Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biopharmaceutical CRO Tier 1, Tier 2, and Tier 3
4 Biopharmaceutical CRO Market by Type
  1. 4.1 Global Biopharmaceutical CRO Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biopharmaceutical CRO Market Size by Type (2021-2032)
  3. 4.3 Global Biopharmaceutical CRO Market Size Share by Type (2021-2032)
5 Biopharmaceutical CRO Market by Application
  1. 5.1 Global Biopharmaceutical CRO Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biopharmaceutical CRO Market Size by Application (2021-2032)
  3. 5.3 Global Biopharmaceutical CRO Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 WuXi AppTec
  2. 6.1.1 WuXi AppTec Company Information
  3. 6.1.2 WuXi AppTec Business Overview
  4. 6.1.3 WuXi AppTec Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 WuXi AppTec Biopharmaceutical CRO Product Portfolio
  6. 6.1.5 WuXi AppTec Recent Developments
  7. 6.2 WuXi Biologics
  8. 6.2.1 WuXi Biologics Company Information
  9. 6.2.2 WuXi Biologics Business Overview
  10. 6.2.3 WuXi Biologics Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 WuXi Biologics Biopharmaceutical CRO Product Portfolio
  12. 6.2.5 WuXi Biologics Recent Developments
  13. 6.3 Hangzhou Tigermed
  14. 6.3.1 Hangzhou Tigermed Company Information
  15. 6.3.2 Hangzhou Tigermed Business Overview
  16. 6.3.3 Hangzhou Tigermed Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Hangzhou Tigermed Biopharmaceutical CRO Product Portfolio
  18. 6.3.5 Hangzhou Tigermed Recent Developments
  19. 6.4 Pharmaron Beijing
  20. 6.4.1 Pharmaron Beijing Company Information
  21. 6.4.2 Pharmaron Beijing Business Overview
  22. 6.4.3 Pharmaron Beijing Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pharmaron Beijing Biopharmaceutical CRO Product Portfolio
  24. 6.4.5 Pharmaron Beijing Recent Developments
  25. 6.5 ICON
  26. 6.5.1 ICON Company Information
  27. 6.5.2 ICON Business Overview
  28. 6.5.3 ICON Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 ICON Biopharmaceutical CRO Product Portfolio
  30. 6.5.5 ICON Recent Developments
  31. 6.6 PPD
  32. 6.6.1 PPD Company Information
  33. 6.6.2 PPD Business Overview
  34. 6.6.3 PPD Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 PPD Biopharmaceutical CRO Product Portfolio
  36. 6.6.5 PPD Recent Developments
  37. 6.7 BioPharma Services
  38. 6.7.1 BioPharma Services Company Information
  39. 6.7.2 BioPharma Services Business Overview
  40. 6.7.3 BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 BioPharma Services Biopharmaceutical CRO Product Portfolio
  42. 6.7.5 BioPharma Services Recent Developments
  43. 6.8 TriStar Technology Group
  44. 6.8.1 TriStar Technology Group Company Information
  45. 6.8.2 TriStar Technology Group Business Overview
  46. 6.8.3 TriStar Technology Group Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 TriStar Technology Group Biopharmaceutical CRO Product Portfolio
  48. 6.8.5 TriStar Technology Group Recent Developments
  49. 6.9 Fortrea
  50. 6.9.1 Fortrea Company Information
  51. 6.9.2 Fortrea Business Overview
  52. 6.9.3 Fortrea Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Fortrea Biopharmaceutical CRO Product Portfolio
  54. 6.9.5 Fortrea Recent Developments
  55. 6.10 Eurofins BioPharma Services
  56. 6.10.1 Eurofins BioPharma Services Company Information
  57. 6.10.2 Eurofins BioPharma Services Business Overview
  58. 6.10.3 Eurofins BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Eurofins BioPharma Services Biopharmaceutical CRO Product Portfolio
  60. 6.10.5 Eurofins BioPharma Services Recent Developments
  61. 6.11 Medicilon
  62. 6.11.1 Medicilon Company Information
  63. 6.11.2 Medicilon Business Overview
  64. 6.11.3 Medicilon Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Medicilon Biopharmaceutical CRO Product Portfolio
  66. 6.11.5 Medicilon Recent Developments
  67. 6.12 Asymchem
  68. 6.12.1 Asymchem Company Information
  69. 6.12.2 Asymchem Business Overview
  70. 6.12.3 Asymchem Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Asymchem Biopharmaceutical CRO Product Portfolio
  72. 6.12.5 Asymchem Recent Developments
  73. 6.13 UBC
  74. 6.13.1 UBC Company Information
  75. 6.13.2 UBC Business Overview
  76. 6.13.3 UBC Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 UBC Biopharmaceutical CRO Product Portfolio
  78. 6.13.5 UBC Recent Developments
  79. 6.14 SanaClis
  80. 6.14.1 SanaClis Company Information
  81. 6.14.2 SanaClis Business Overview
  82. 6.14.3 SanaClis Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 SanaClis Biopharmaceutical CRO Product Portfolio
  84. 6.14.5 SanaClis Recent Developments
  85. 6.15 TFS HealthScience
  86. 6.15.1 TFS HealthScience Company Information
  87. 6.15.2 TFS HealthScience Business Overview
  88. 6.15.3 TFS HealthScience Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 TFS HealthScience Biopharmaceutical CRO Product Portfolio
  90. 6.15.5 TFS HealthScience Recent Developments
  91. 6.16 Parexel
  92. 6.16.1 Parexel Company Information
  93. 6.16.2 Parexel Business Overview
  94. 6.16.3 Parexel Biopharmaceutical CRO Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Parexel Biopharmaceutical CRO Product Portfolio
  96. 6.16.5 Parexel Recent Developments
7 North America
  1. 7.1 North America Biopharmaceutical CRO Market Size (2021-2032)
  2. 7.2 North America Biopharmaceutical CRO Market Size by Type
  3. 7.2.1 North America Biopharmaceutical CRO Market Size by Type (2021-2026)
  4. 7.2.2 North America Biopharmaceutical CRO Market Size by Type (2027-2032)
  5. 7.2.3 North America Biopharmaceutical CRO Market Share by Type (2021-2032)
  6. 7.3 North America Biopharmaceutical CRO Market Size by Application
  7. 7.3.1 North America Biopharmaceutical CRO Market Size by Application (2021-2026)
  8. 7.3.2 North America Biopharmaceutical CRO Market Size by Application (2027-2032)
  9. 7.3.3 North America Biopharmaceutical CRO Market Share by Application (2021-2032)
  10. 7.4 North America Biopharmaceutical CRO Market Size by Country
  11. 7.4.1 North America Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biopharmaceutical CRO Market Size by Country (2021-2026)
  13. 7.4.3 North America Biopharmaceutical CRO Market Size by Country (2027-2032)
  14. 7.4.4 North America Biopharmaceutical CRO Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biopharmaceutical CRO Market Size (2021-2032)
  2. 8.2 Europe Biopharmaceutical CRO Market Size by Type
  3. 8.2.1 Europe Biopharmaceutical CRO Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biopharmaceutical CRO Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biopharmaceutical CRO Market Share by Type (2021-2032)
  6. 8.3 Europe Biopharmaceutical CRO Market Size by Application
  7. 8.3.1 Europe Biopharmaceutical CRO Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biopharmaceutical CRO Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biopharmaceutical CRO Market Share by Application (2021-2032)
  10. 8.4 Europe Biopharmaceutical CRO Market Size by Country
  11. 8.4.1 Europe Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biopharmaceutical CRO Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biopharmaceutical CRO Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biopharmaceutical CRO Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biopharmaceutical CRO Market Size (2021-2032)
  2. 9.2 China Biopharmaceutical CRO Market Size by Type
  3. 9.2.1 China Biopharmaceutical CRO Market Size by Type (2021-2026)
  4. 9.2.2 China Biopharmaceutical CRO Market Size by Type (2027-2032)
  5. 9.2.3 China Biopharmaceutical CRO Market Share by Type (2021-2032)
  6. 9.3 China Biopharmaceutical CRO Market Size by Application
  7. 9.3.1 China Biopharmaceutical CRO Market Size by Application (2021-2026)
  8. 9.3.2 China Biopharmaceutical CRO Market Size by Application (2027-2032)
  9. 9.3.3 China Biopharmaceutical CRO Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biopharmaceutical CRO Market Size (2021-2032)
  2. 10.2 Asia Biopharmaceutical CRO Market Size by Type
  3. 10.2.1 Asia Biopharmaceutical CRO Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biopharmaceutical CRO Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biopharmaceutical CRO Market Share by Type (2021-2032)
  6. 10.3 Asia Biopharmaceutical CRO Market Size by Application
  7. 10.3.1 Asia Biopharmaceutical CRO Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biopharmaceutical CRO Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biopharmaceutical CRO Market Share by Application (2021-2032)
  10. 10.4 Asia Biopharmaceutical CRO Market Size by Country
  11. 10.4.1 Asia Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biopharmaceutical CRO Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biopharmaceutical CRO Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biopharmaceutical CRO Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biopharmaceutical CRO Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biopharmaceutical CRO Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biopharmaceutical CRO Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biopharmaceutical CRO Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biopharmaceutical CRO Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst